We received news that AB Science has paused its masitinib studies worldwide, including its phase 3 ALS trial. The company’s announcement of this breaking news can be found here.
AB Science Announces a Voluntary Hold in the Clinical Studies of Masitinib
![Masitinib](/sites/default/files/styles/hero_image_small/public/2021-06/istock_10353204_large_research-team-with-clear-solution.jpg?h=2f03dbdf&itok=sJyzvTMS)
Join the conversation. Please comment below.